JP2024501757A5 - - Google Patents

Info

Publication number
JP2024501757A5
JP2024501757A5 JP2023540859A JP2023540859A JP2024501757A5 JP 2024501757 A5 JP2024501757 A5 JP 2024501757A5 JP 2023540859 A JP2023540859 A JP 2023540859A JP 2023540859 A JP2023540859 A JP 2023540859A JP 2024501757 A5 JP2024501757 A5 JP 2024501757A5
Authority
JP
Japan
Prior art keywords
rna
binding
ligand
protein
motif
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023540859A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024501757A (ja
Filing date
Publication date
Priority claimed from GBGB2107188.1A external-priority patent/GB202107188D0/en
Application filed filed Critical
Priority claimed from PCT/GB2022/050004 external-priority patent/WO2022148955A1/en
Publication of JP2024501757A publication Critical patent/JP2024501757A/ja
Publication of JP2024501757A5 publication Critical patent/JP2024501757A5/ja
Pending legal-status Critical Current

Links

JP2023540859A 2021-01-05 2022-01-05 遺伝子組換え細胞の製造方法 Pending JP2024501757A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202163133942P 2021-01-05 2021-01-05
US202163133945P 2021-01-05 2021-01-05
US63/133,942 2021-01-05
US63/133,945 2021-01-05
GBGB2107188.1A GB202107188D0 (en) 2021-05-19 2021-05-19 Method for producing genetically modified cells
GB2107188.1 2021-05-19
PCT/GB2022/050004 WO2022148955A1 (en) 2021-01-05 2022-01-05 Method for producing genetically modified cells

Publications (2)

Publication Number Publication Date
JP2024501757A JP2024501757A (ja) 2024-01-15
JP2024501757A5 true JP2024501757A5 (https=) 2024-12-23

Family

ID=81255823

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023540859A Pending JP2024501757A (ja) 2021-01-05 2022-01-05 遺伝子組換え細胞の製造方法

Country Status (5)

Country Link
US (1) US20240067954A1 (https=)
EP (1) EP4274893B1 (https=)
JP (1) JP2024501757A (https=)
CA (1) CA3207144A1 (https=)
WO (1) WO2022148955A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11970719B2 (en) * 2017-11-01 2024-04-30 The Regents Of The University Of California Class 2 CRISPR/Cas compositions and methods of use
WO2020051562A2 (en) 2018-09-07 2020-03-12 Beam Therapeutics Inc. Compositions and methods for improving base editing
EP3847254A4 (en) 2018-09-07 2022-08-10 Beam Therapeutics Inc. COMPOSITIONS AND METHODS FOR DELIVERING A NUCLEOBASE EDITING SYSTEM
AU2020215730A1 (en) 2019-01-31 2021-07-29 Beam Therapeutics Inc. Nucleobase editors having reduced non-target deamination and assays for characterizing nucleobase editors
CN120174005A (zh) 2019-02-13 2025-06-20 比姆医疗股份有限公司 具有用于修饰靶标序列中核碱基的腺苷脱氨酶碱基编辑器的经修饰的免疫细胞
EP4034138A4 (en) 2019-09-27 2024-07-31 Beam Therapeutics, Inc. COMPOSITIONS AND METHODS FOR THE TREATMENT OF LIQUID CANCERS
CA3196831A1 (en) 2020-09-25 2022-03-31 Beam Therapeutics Inc. Fratricide resistant modified immune cells and methods of using the same
AU2024270764A1 (en) 2023-05-15 2025-12-04 Nchroma Bio, Inc. Compositions and methods for epigenetic regulation of hbv gene expression
WO2024240138A1 (zh) * 2023-05-22 2024-11-28 江西农业大学 基于perv逆转录酶的先导编辑系统
CN121100181A (zh) * 2023-05-26 2025-12-09 正序(上海)生物医药科技有限公司 基因编辑系统及其用途

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3687808A (en) 1969-08-14 1972-08-29 Univ Leland Stanford Junior Synthetic polynucleotides
US4625014A (en) 1984-07-10 1986-11-25 Dana-Farber Cancer Institute, Inc. Cell-delivery agent
US5034506A (en) 1985-03-15 1991-07-23 Anti-Gene Development Group Uncharged morpholino-based polymers having achiral intersubunit linkages
US5061641A (en) 1988-04-01 1991-10-29 Immunomedics, Inc. Method for radiolabeling proteins
US5057301A (en) 1988-04-06 1991-10-15 Neorx Corporation Modified cellular substrates used as linkers for increased cell retention of diagnostic and therapeutic agents
US5602240A (en) 1990-07-27 1997-02-11 Ciba Geigy Ag. Backbone modified oligonucleotide analogs
US5489677A (en) 1990-07-27 1996-02-06 Isis Pharmaceuticals, Inc. Oligonucleoside linkages containing adjacent oxygen and nitrogen atoms
WO1994012520A1 (en) 1992-11-20 1994-06-09 Enzon, Inc. Linker for linked fusion polypeptides
US6165476A (en) 1997-07-10 2000-12-26 Beth Israel Deaconess Medical Center Fusion proteins with an immunoglobulin hinge region linker
US20100063258A1 (en) 2006-06-28 2010-03-11 The Board Of Trustees Of The Leland Stanford Junior University Fusion protein constructs
DK2476689T3 (en) 2007-05-10 2016-01-18 Agilent Technologies Inc Thiocarbonbeskyttende groups for RNA synthesis
EP3415528B1 (en) 2011-04-13 2021-05-26 Bristol-Myers Squibb Company Fc fusion proteins comprising novel linkers or arrangements
AU2013266968B2 (en) 2012-05-25 2017-06-29 Emmanuelle CHARPENTIER Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
CN104619727B (zh) 2012-06-25 2019-04-05 布里格姆及妇女医院股份有限公司 靶向治疗
EP2840140B2 (en) 2012-12-12 2023-02-22 The Broad Institute, Inc. Crispr-Cas based method for mutation of prokaryotic cells
DK2931891T3 (da) 2012-12-17 2019-08-19 Harvard College Rna-styret modificering af menneskelige genomer
US9234213B2 (en) 2013-03-15 2016-01-12 System Biosciences, Llc Compositions and methods directed to CRISPR/Cas genomic engineering systems
CN112301024A (zh) 2013-03-15 2021-02-02 通用医疗公司 使用RNA引导的FokI核酸酶(RFN)提高RNA引导的基因组编辑的特异性
US20140273230A1 (en) 2013-03-15 2014-09-18 Sigma-Aldrich Co., Llc Crispr-based genome modification and regulation
US20170233762A1 (en) * 2014-09-29 2017-08-17 The Regents Of The University Of California Scaffold rnas
JP7044373B2 (ja) 2015-07-15 2022-03-30 ラトガース,ザ ステート ユニバーシティ オブ ニュージャージー ヌクレアーゼ非依存的な標的化遺伝子編集プラットフォームおよびその用途
CN110214183A (zh) 2016-08-03 2019-09-06 哈佛大学的校长及成员们 腺苷核碱基编辑器及其用途
EP3565608A4 (en) 2017-01-05 2020-12-16 Rutgers, The State University of New Jersey TARGETED GENE EDITING PLATFORM INDEPENDENT OF BICATENARY DNA BREAKAGE AND ITS USES
AU2020466994A1 (en) * 2019-09-17 2022-04-21 Rutgers, The State University Of New Jersey Highly efficient DNA base editors mediated by RNA-aptamer recruitment for targeted genome modification and uses thereof

Similar Documents

Publication Publication Date Title
JP2024501757A5 (https=)
JP2024088668A5 (https=)
De Vargas et al. DNA looping generated by DNA bending protein IHF and the two domains of lambda integrase
Brooks et al. Making sense of G‐quadruplex and i‐motif functions in oncogene promoters
Cao et al. TGGA repeats impair nucleosome formation
JP7093728B2 (ja) 化学的に修飾されたガイドrnaを使用する高特異性ゲノム編集
Gronostajski Site-specific DNA binding of nuclear factor I: effect of the spacer region
Bakalkin et al. p53 binds single-stranded DNA ends and catalyzes DNA renaturation and strand transfer.
JP2022166077A5 (https=)
JP2023501223A5 (https=)
JPH04507198A (ja) 核酸の交雑、増幅方法
Tinker et al. Transcriptional activation by a DNA-tracking protein: structural consequences of enhancement at the T4 late promoter
CN105950639A (zh) 金黄色葡萄球菌CRISPR/Cas9系统的制备及其在构建小鼠模型中的应用
JP2024502114A5 (https=)
JP2024511163A5 (https=)
Shionoya et al. Artificial metallo-DNA: a bio-inspired approach to metal array programming
JP2024502348A5 (https=)
JP2021522825A5 (https=)
JPS60244290A (ja) レトロウイルスのゲノムの少なくとも一部を含む、真核生物細胞中のタンパク質のクロ−ニングと発見ウイルスベクトル、このベクトルによつて感染された真核生物細胞およびこのような細胞と得られたタンパク質の利用方法
JP2023549125A5 (https=)
Wei et al. Progress in aptamer screening methods
Leonhardt et al. Functional links between nuclear structure, gene expression, DNA replication, and methylation
Sharma et al. Binding of the bacteriophage T4 transcriptional activator, MotA, to T4 middle promoter DNA: evidence for both major and minor groove contacts
Witkowski Fifty years on: molecular biology's hall of fame
Shen et al. A technique for relating long-range base pairing on single-stranded DNA and eukaryotic RNA processing